Reducing systolic blood pressure to less than 120 mm Hg reduced cardiovascular event risk
Research Highlights:
In a 3-year trial, intensive treatment with antihypertensive medication to reduce systolic blood pressure, the top number, to less than 120 mm Hg reduced cardiovascular disease events among people at high-risk for cardiovascular disease by 12% compared to standard treatment with a target of less than 140 mm Hg.
The effects were consistent regardless of participants’ diabetes status (Type 1, Type 2 or none) or history of stroke.
Embargoed until 8 a.m. ET, Monday, Nov. 13, 2023
PHILADELPHIA, ...













